Morgan Stanley’s BIOMED REALTY TRUST INC BMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-4,006,167
Closed -$94.9M 6973
2015
Q4
$94.9M Sell
4,006,167
-132,151
-3% -$3.07M 0.03% 514
2015
Q3
$82.7M Buy
4,138,318
+46,638
+1% +$933K 0.03% 546
2015
Q2
$79.1M Buy
4,091,680
+542,699
+15% +$11.2M 0.03% 620
2015
Q1
$80.4M Sell
3,548,981
-410,598
-10% -$9.43M 0.03% 589
2014
Q4
$85.3M Buy
3,959,579
+2,662,234
+205% +$56.7M 0.03% 577
2014
Q3
$26.2M Buy
1,297,345
+123,979
+11% +$2.69M 0.01% 1230
2014
Q2
$25.6M Buy
1,173,366
+406,545
+53% +$8.64M 0.01% 1229
2014
Q1
$15.7M Sell
766,821
-266,797
-26% -$5.26M 0.01% 1584
2013
Q4
$18.7M Buy
1,033,618
+353,186
+52% +$6.69M 0.01% 1397
2013
Q3
$12.7M Buy
680,432
+349,283
+105% +$6.86M 0.01% 1580
2013
Q2
$6.7M Buy
+331,149
New +$7.17M ﹤0.01% 2055

Other funds holding BMR

Morgan Stanley's BMR Position: Q1 2016 in Review

Morgan Stanley sold out of BIOMED REALTY TRUST INC (BMR) in Q1 2016, closing a stake of 4,006,167 shares — an estimated $94.9M sold.

Morgan Stanley first reported a position in BMR in Q2 2013 and held it in 11 quarters. The position peaked at $94.9M in Q4 2015. 4 funds tracked by Wall St. Rank hold BMR as of Q1 2016.

  • Morgan Stanley reported no remaining BIOMED REALTY TRUST INC position as of Q1 2016 after selling out during the quarter.
  • Morgan Stanley sold 4,006,167 BIOMED REALTY TRUST INC shares in Q1 2016, an estimated $94.9M.
  • Morgan Stanley first reported a position in BIOMED REALTY TRUST INC in Q2 2013 and held it in 11 quarters.
  • Morgan Stanley's BIOMED REALTY TRUST INC position peaked at $94.9M in Q4 2015.
  • 4 funds tracked by Wall St. Rank held BIOMED REALTY TRUST INC as of Q1 2016.

Based on Morgan Stanley's 13F filing for Q1 2016, filed 12 May 2016.